CTN :45565466
02 Jul, 2026
20.00 Lacs
Tender For corrigendum : supply of generic drugs and medicine - antacid liquid,each 5ml contains dried aluminium hydroxide gel 250 mg, magnesium hydroxide 250mg, activated polydimethyl siloxane 50mg, beclomethasone inhalation ip 200 mcg/dose, betamethasone lotion ip 0.05 o/o, black disinfectant fluid (phenyl) as per schedule o grade iii, budesonide nebulizer suspension 0.25mg/ml, budesonide powder for inhalation 200 mcg, calcium and class="text-red-selected">vitamin d3 suspension (ea
ch 5 ml
contains
cal
cium
carbonate equivalent to elemental
cal
cium 250 mg,
class="text-red-sele
cted">vitamin d3 125 iu ),
cap amoxy
cillin ip 500mg,
cap amoxy
cillin and
cloxa
cillin 250 + 250 mg,
cap
cephalexin ip 250 mg,
cap
cephalexin ip 500 mg,
cap
clindamy
cin ip 300 mg,
cap doxy
cy
cline ip 100 mg,
cap itra
conazole 100 mg,
cap omeprazole ip 20 mg,
cap pantoprazole 40mg and domperidone 30mg sr ip ,
cap pregabalin ip 75 mg,
cap
class="text-red-sele
cted">vitamin e 400 mg,
ceruminolyti
c drops (wax dissolving ear drops) paradi
chlorobenzene 2 o/o , benzo
caine 2.7 o/o ,
chlorbutol 5 o/o, turpentine oil 15 o/o,
chlorhexidine mouthwash ip 0.2 o/o,
chole
cal
ciferol granules 60,000 iu /gm,
clotrimazole 1 o/o with be
clomethasone dipropionate 0.025 o/o ear drops,
compound benzoin tin
cture ip,
cough syrup/expe
ctorant(50) ml, dental gel
choline sali
cylate 8.7 o/o, benzalkonium
chloride 0.01 o/o, ligno
caine h
cl 2 o/o (flavoured gel base), dinoprostone
cream/ gel 0.5 mg dinoprostone in syringe, domperidone oral drops 10mg/ ml (10ml), eye drop moxifloxa
cin 0.5% w/v ophthalmi
c solution ip 5ml size, eye drop.
ciprofloxa
cin 0.3 o/o and dexamethasone 0.1 , eye drops
carboxymethyl
cellulose ip 0.5%, eye drops
chlorampheni
col ip 0.5 0/0, eye drops
ciprofloxa
cin ip 0.3 o/o w/v, eye dropstimolol ip 0.5 o/o w/v, eye dropstobramy
cin 0.3% [331], formaldehyde solution (34.5 per. - 38 per.), formoterol fumerate & budesonide powder for inhalation ip 6 m
cg + 200 m
cg, gluteraldehyde solution 2%, human albumin solution ip 20%, hydrogen peroxide solution ip 6 o/o (20 vol), hydroxypropylmethyl
cellulose solution 20 mg/ ml, inj. a
cetyl
cystine solution usp 200 mg/ml, inj. adenosine ip 6 mg/2ml, inj. adrenaline ip 1mg/ml im/iv use, inj. amika
cin ip 500 mg, inj. amika
cin ip 100 mg, inj. aminophylline ip 25 mg/ml, inj. amiodarone hydro
chloride 50 mg/ml, inj. amoxi
cillin and potassium
clavulanate ip 1.2gm, inj. artesunate inje
ction 60 mg (i.m. i.v.use) ea
ch
combo pa
ck
contains artesunate 60 mgvial, sodium bi
carbonate inje
ction ip 5 o/o w/v (1ml ampoule),sodium
chloride ip 0.9o/o w/v (5ml ampoule), inj. atra
curium 10 mg/ml, inj. atropine sulphate 0.6mg/ml, inj. benzathine benzylpeni
cillin ip 12 la
c units, inj. benzathine benzylpeni
cillin ip 6 la
c units, inj. biphasi
c isophane insulin ip (30 % soluble insulin and 70 % isophane insulin) . 40 iu/ml(r-dna origin), inj. bupiva
caine hydo
chloride in dextrose usp ea
ch ml
contains bupiva
caine hydro
chloride 5.0 mg dextrose 80.0 mg, inj. bupiva
caine ip 0.5%, inj.
caffeine
citrate usp 20mg/ml (equivalent to 10 mg
caffeine base/ml) 3ml size, inj.
cal
cium glu
conateip 10% (iv use), inj.
carboprost tromethamine ip ea
ch ml
contains
carboprost 0.25 mg/ml, inj.
cefoperazone and sulba
ctum for (
cefoperazone sodium eq.to
cefoperazone 1gm and sulba
ctum sodium eq. to sulba
ctum 0.5gm)(im/iv use), inj.
cefotaxime ip 1 g, inj.
cefotaxime ip 250 mg, inj.
ceftazidime ip 1g, inj.
ceftazidime ip 500 mg, inj.
ceftazidime ip 250 mg, inj.
ceftriaxone ip 500mg/vial, inj.
ceftriaxone 1 gm + tazoba
ctum 125 mg , inj.
ceftriaxone ip 1g /vial, inj.
ceftriaxone ip 250 mg/vial, inj.
chloroquine phosphate ip 40 mg/ ml, inj.
ciprofloxa
cin ip 200mg/100ml, inj.
compound sodium la
ctate . ip, inj. dexamethasone ip 8mg/2ml, inj. dextrose ip 25% w/v, inj. dextrose ip 10%, inj. dextrose ip 5%, inj. diazepam ip 10mg/2ml (1m/iv use), inj. di
clofena
c sodium ip 25 mg/ ml (im/iv use), inj. di
cy
clomine ip 10 mg /ml, inj. dobutamine inj ip 50mg/ml/250mg (vial/)dobutamine ip 250 mg/5ml(amp), inj. dopamine hydro
chloride ip 40 mg/ml, inj. dried fa
ctor viii fra
ction ip (iv use) 1000 iu/vi